Sixteen months into this virus, our government has nothing to offer us in terms of treatment in the hospital but remdesivir at $3,100 a dose and zero treatment options at the critical early stage, when serious complications can be pre-empted. Now, a new study from the University of Iowa shows what we knew all along – that remdesivir failed to reduce mortality one iota. Why are we to believe the same government entities about embracing the clot shots and shunning so many other cheaper and...





















